Silver Oak Securities, Inc Gilead Sciences, Inc. Transaction History

Silver Oak Securities, Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 05, 2023	SELL	$77.31 - $88.08 $16,080 - $18,320	-208 Reduced 4.28%	4,655 $386,000
Q4 2022 Feb 02, 2023	SELL	$62.32 - $89.47 $128,503 - $184,487	-2,062 Reduced 29.78%	4,863 $417,000
Q3 2022 Oct 20, 2022	SELL	$59.54 - $68.01 $178 - $204	-3 Reduced 0.04%	6,925 $427,000
Q2 2022 Aug 15, 2022	BUY	$57.72 - $65.01 $16,911 - $19,047	293 Added 4.42%	6,928 $421,000
Q1 2022 May 10, 2022	BUY	$57.92 - $72.58 $384,299 - $481,568	6,635 New	6,635 $413,000

1,927

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Silver Oak Securities, Inc, based on Form 13F filings with the SEC.

Stay updated on Silver Oak Securities, Inc with notifications on news.